Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2006, Vol. 107, No. 5, pp. 2037-2044.
Prepublished online as a Blood First Edition Paper on November 17, 2005; DOI 10.1182/blood-2005-07-2760.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-07-2760v1
107/5/2037    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, N.
Right arrow Articles by Emilie, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, N.
Right arrow Articles by Emilie, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 12, 2005
Accepted October 19, 2005

GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response

Nicolas Cohen, Enguerran Mouly, Haifa Hamdi, Marie-Christine Maillot, Marc Pallardy, Veronique Godot, Francis Capel, Axel Balian, Sylvie Naveau, Pierre Galanaud, Francois M Lemoine, and Dominique Emilie*

INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France
CNRS UMR 7087/UPMC, Hopital Pitie-Salpetriere, Assistance Publique-Hopitaux de Paris, Paris, France
INSERM UMR-S 461, Faculte de Pharmacie, Universite Paris-Sud, Chatenay-Malabry, France
INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France; Service d'Hepato-Gastro-Enterologie, Hopital Antoine Beclere, Assistance Publique- Hopitaux de Paris, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France
INSERM UMR-S131, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France; Service de Microbiologie-Immunologie biologique, Hopital Antoine Beclere, Assistance Publique- Hopitaux de Paris, Institut Paris-Sud sur les Cytokines, Universite Paris-Sud, Clamart, France

* Corresponding author; email: emilie{at}ipsc.u-psud.fr.

Interleukin (IL)-10 and glucocorticoids (GC) inhibit the ability of antigen-presenting dendritic cells (DC) to stimulate T lymphocytes. We show that induction of GILZ (Glucocorticoid-Induced Leucine Zipper) is involved in this phenomenon. IL-10, dexamethasone (DEX) and transforming growth factor (TGF){beta} stimulate GILZ production in human DC derived from monocytes and from CD34+ cells. GILZ is necessary and sufficient for DEX, IL-10 and TGF{beta} modulation of CD80, CD83, CD86, ILT3 and B7-H1 expression by DC and alteration of DC functions. GILZ stimulates the production of IL-10 by immature DC and it prevents the production of inflammatory chemokines by CD40L-activated DC. In contrast, GILZ has no effect on CD40L-mediated inhibition of phagocytosis, indicating that it affects some but not all aspects of DC maturation. GILZ also prevents DC from activating antigen-specific T lymphocyte responses. Administration of GC to patients stimulates GILZ expression in their circulating antigen-presenting cells, and this contributes to the weak lymphocyte responses of GC-treated patients. Thus, regulation of GILZ expression is an important factor determining the decision of DC whether or not to stimulate T lymphocytes, and IL-10, GC and TGF{beta} share this mechanism for influencing DC functions and the balance between immune response and tolerance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
E. Ayroldi and C. Riccardi
Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
FASEB J, November 1, 2009; 23(11): 3649 - 3658.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Chamorro, J. J. Garcia-Vallejo, W. W. J. Unger, R. J. Fernandes, S. C. M. Bruijns, S. Laban, B. O. Roep, B. A. 't Hart, and Y. van Kooyk
TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program
J. Immunol., September 1, 2009; 183(5): 2984 - 2994.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Brenk, M. Scheler, S. Koch, J. Neumann, O. Takikawa, G. Hacker, T. Bieber, and D. von Bubnoff
Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol., July 1, 2009; 183(1): 145 - 154.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Terness, T. Oelert, S. Ehser, J. J. Chuang, I. Lahdou, C. Kleist, F. Velten, G. J. Hammerling, B. Arnold, and G. Opelz
Mitomycin C-treated dendritic cells inactivate autoreactive T cells: Toward the development of a tolerogenic vaccine in autoimmune diseases
PNAS, November 25, 2008; 105(47): 18442 - 18447.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Hamdi, V. Godot, M.-C. Maillot, M. V. Prejean, N. Cohen, R. Krzysiek, F. M. Lemoine, W. Zou, and D. Emilie
Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper
Blood, July 1, 2007; 110(1): 211 - 219.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Raja Gabaglia, Y. Diaz de Durana, F. L. Graham, J. Gauldie, E. E. Sercarz, and T. A. Braciak
Attenuation of the Glucocorticoid Response during Ad5IL-12 Adenovirus Vector Treatment Enhances Natural Killer Cell-Mediated Killing of MHC Class I-Negative LNCaP Prostate Tumors
Cancer Res., March 1, 2007; 67(5): 2290 - 2297.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Shi, K. Luo, D. Xia, T. Chen, G. Chen, Y. Jiang, N. Li, and X. Cao
DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses
Blood, October 15, 2006; 108(8): 2678 - 2686.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020